Professional

Professional

Fetal Medicine Foundation Series – Series Editor: K. H. Nicolaides

• The 11-14-week scan – The diagnosis of fetal abnormalities (English Version)

 

• 孕11-14週超聲 – 中文繁體版

  • 第一部份: 簡介
  • 第二部份: 早期妊娠染色體異常的診斷
  • 第三部份: 染色體異常的超聲特徵
  • 第四部份: 頸項透明層增厚而核型正常的胎兒
  • 第五部份: 多胎妊娠

 

• 孕11-14週超聲 – 中文簡體版
  • 簡介及早期妊娠染色體異常的診斷
  • 染色體異常的超聲特徵
  • 頸項透明層增厚而核型正常的胎兒
  • 多胎妊娠 

 

• Diagnosis of fetal abnormalities – The 18-23-week scan

1. Introduction

2. Standard views for examination of the fetus

3. Centro nervous system

4. Face

5. Cardiovascular system

6. Pulmonary abnormalities

7. Anterior abdominal wall

8. Gastrointestinal tract

9. Kidneys and urinary tract

10. Skeleton

11. Features of chromosomal defects

12. Fetal tumors

13. Hydrops fetalis

14. Small for festational age

15. Abnormalities of the amniotic fluid volume

16. Appedix I/II/III

 

The Fetal Medicine Foundation – The First Trimester Screening Program – Risk Calculation (2008)

Guide for the First Trimester Screening Module Update 2008 – 2009 Algorithm

Program Manual for First Trimester Screening Program Update 2009

 

• POSTPARTUM HAEMORRHAGE (FIGO. 2006)
  • Introduction
  • Chapter 1: Postpartum hemorrhage today: living in the shadow of the Taj Mahal
  • Chapter 2: Definitions and classifications
  • Chapter 3: Vital statistics: an overview
  • Chapter 4: Pitfalls in assessing blood loss and decision to transfer
  • Chapter 5: Assessing and replenishing lost volume
  • Chapter 6: Blood loss: accuracy of visual estimation
  • Chapter 7: Doppler evaluation of hemodynamic changes in uterine blood flow
  • Chapter 8: Pathophysiology of postpartum hemorrhage and third stage of labor
  • Chapter 9: Obstetric trauma
  • Chapter 10: Placental abnormalities
  • Chapter 11: Active management of the third stage of labor
  • Chapter 12: Misoprostol: theory and practice
  • Chapter 13: Labor ward drills
  • Chapter 14: Non-pneumatic anti-shock garment
  • Chapter 15: Special circumstances: Jehovah’s Witnesses, those who refuse blood transfusion
  • Chapter 16: Misoprostol in practice
  • Chapter 17: Management of postpartum hemorrhage at the community level
  • Chapter 18: Oral misoprostol for prevention of postpartum hemorrhage by paramedical
  • Chapter 19: Overview of misoprostol studies in postpartum hemorrhage
  • Chapter 20: Resuscitation
  • Chapter 21: Equipment tray for postpartum hemorrhage
  • Chapter 22: Building hospital systems for managing major obstetric hemorrhage
  • Chapter 23: Bleeding from the lower genital tract
  • Chapter 24: Adherent placenta: new management options
  • Chapter 25 Acquired and congenital hemostatic disorders in pregnancy and the puerperium
  • Chapter 26: The use of recombinant factor VIIa
  • Chapter 27: Standard medical therapy
  • Chapter 28: Internal uterine tamponade
  • Chapter 29: The balloon internal uterine tamponade as a diagnostic test
  • Chapter 30: Embolization
  • Chapter 31: Conservative surgical management (Part I, Part II)
  • Chapter 32: Internal iliac (hypogastric) artery ligation
  • Chapter 33: The pelvic pressure pack
  • Chapter 34: Peripartum hysterectomy
  • Chapter 35: The management of secondary postpartum hemorrhage
  • Chapter 36: Pathology of the uterus (Part I, Part II, Part III)
  • Chapter 37: Severe acute maternal morbidity
  • Chapter 38: Sheehan’s syndrome
  • Chapter 39: An institutional experience
  • Chapter 40: Familial consequences
  • Chapter 41: Litigation: an international perspective
  • Chapter 42: The obstetrician confronts postpartum hemorrhage
  • Chapter 43: The midwife confronts postpartum hemorrhage
  • Chapter 44: Sepsis and postpartum hemorrhage
  • Chapter 45: The single-unit transfusion in the bled-out obstetric patient
  • Chapter 46: Out-of-hospital deliveries
  • Chapter 47: Intraoperative autologous blood tranfusion
  • Chapter 48: Treating hemorrhage from secondary abnominal pregnancy: then and now
  • Chapter 49: Combating postpartum hemorrhage in India: moving forward
  • Chapter 50: Eliminating mortality: lessons from Lublin Province in Poland
  • Chapter 51: Postpartum hemorrage in Iran
  • Chapter 52: Postpartum hemorrhage and maternal mortality in Nigeria
  • Chapter 53: Postpartum hemorrhage in Asian countries: available data and interpretation

 

Update Journal

• Which Antiepileptic Drug Is Safest in Pregnancy?
• Neonatal Outcomes Associated with Planned Vaginal Versus Planned Primary Cesarean Delivery
• Labor Induction Increase Risk of Rare Amniotic Fluid Emboli
• Common Problems in Pediatric and Adolescent Gynecology
• Women May Not Need t Delay pregnancy After an Initial Miscarriage (Medscaped – Women’s Health News, August 13, 2010)
• Menopausal Hormone Therapy: 2010 Guideline From NAMS and Endocrine Society – Medscape – Ob/Gyn & Women’s Health MedPulse, August 13, 2010)
• Managing Metastatic Breast Cancer in the Community Setting: A Clinical Practice Assessment – Medscape – Ob/Gyn & Women’s Health MedPulse, September 1, 2010)
• Chorionic Villus Sampling at 11 to 13 Weeks Not Linked to Hypertensive Disorders in Pregnancy- Medscape – Ob/Gyn & Women’s Health, September 1, 2010)

 

Presentations:

• Preimplantation Genetic Diagnosis For Alpha Thalassemia – Dr. KY Leung
• Nursing Management of Post Partum Haemorrhage – Ms. LF Ho
• Post Partum Haemorrhage Risk Factors Prevention – Prof. Terence Lao
• Application of CTG – Prof. Terence Lao
• Interpretation of CTG & CFHM during Antepartum & Intrapartum Peroids – Ms. LF Ho
• CTG – Physiological and Pathological Control of Fetal heart Rate Patterns – Prof. Terence Lao
• Second Trimester Maternal Serum Screening Test in China – Prof. Bian Xuming

 

IC Presentation (Doctors)

Puerperal Fever

Hypothyroidism in Pregnancy